Advisors & Partners

We are partnering with healthcare and industry experts from world-leading institutions like USC, and Berkeley. Together, we are transforming the future of medicine.

Advisors & Partners

We are partnering with healthcare and industry experts from world-leading institutions like Stanford, USC, and Berkeley. Together, we are transforming the future of medicine.

Clinical Advisory board

Cristina Ferrone, MD
/ GI Surgical Oncologist
/ Massachusetts General Hospital

Dr. Ferrone is the Surgical Director of the Liver Program in the Division of General Surgery at Massachusetts General Hospital. She has 22 years of experience and her specialties include surgical oncology and surgery. She focuses in gastrointestinal malignancies and metastatic liver disease, immunologic treatment of solid tumors and GI malignancies and primary hepatic and pancreatic cancers.

Darcy V. Spicer, MD
/ Medical Oncology
/ Keck School of Medicine, USC

Dr. Spicer is the associate Professor of Clinical Medicine and Chief of the Division of Medical Oncology at USC Norris Comprehensive Cancer and Hospital. He chairs Keck's Institutional Review Board. He is also a medical oncology attending physician at both theLAC+USC Medical Center and the USC Norris Comprehensive Cancer Center and the General Medicine Ward Attending Physician at LAC+USC Medical Center. Dr. Spicer is the founder of Balance Pharmaceuticals based in Los Angeles.

Linda Rosenstock, MD, MPH
/ Ethics and Health Policy
/ Fielding School of Public Health, UCLA

Dr. Rosenstock is the Dean Emeritus of UCLA Fielding School of Public Health. She also serves as the Chairperson of the Board of TSO3 Inc., Professor of Health Policy and Management, and Professor of Environmental Health Sciences and Medicine at UCLA. Dr. Rosenstock focuses on clinical care, health care delivery, population health, research and health and regulatory policy. She also served as Director of the National Institute for Occupational Safety and Health where she created the National Occupational Research Agenda- a framework for guiding occupational safety and health research- to identify and address pressing workplace health risk.

George A. Poultsides, MD, MS, FACS
/ Surgical Oncology
/ Stanford University

Associate Professor of Surgery (General Surgery) at the Stanford University Medical Center. Dr. Poultsides specializes in the removal of liver, pancreatic, and other abdominal tumors. He is currently researching outcomes analysis following multidisciplinary treatment of hepatic, pancreatic and gastrointestinal malignancies. He also developed a novel interdisciplinary research program assessing the completeness of surgical resection for pancreatic cancer. Dr. Poultsides is a recipient of the John AustinCollins, MD annual teaching award from the Stanford Surgery.

Eren Berber, MD
/ Endocrinology and Surgical Oncology
/ Cleveland Clinic

Associate Professor of Surgery at the Cleveland Clinic, where he also serves as the Director of Robotic Endocrine Surgery and co-director of Liver Tumor Ablation Program. His specialties include laparoscopic and robotic liver surgery, laparoscopic liver tumor ablation, robotic surgery, conventional and minimally invasive endocrine surgery (thyroid, parathyroid, adrenal and pancreas). Dr. Berber has authored120 peer-reviewed papers and 15 book chapters. He serves on the Editorial Board of Surgical Laparoscopy and Endoscopy. He is a member of numerous surgical societies, including American College of Surgeons and serves in multiple committees.

Strategic Advisor

Jonathan DiOrio
/ Strategic Advisor

Jonathan is an active investor and operating advisor to a number of technology based companies across the world. Until recently, Jonathan was a senior executive at Uber, leading Uber’s FinTech Practice Globally and US Business Development. Prior to that, he ran Uber’s worldwide partnerships with Travel and Entertainment companies and helped to scale the 100+ person Uber Business team as one of its earliest members.

Jonathan spent the last two decades in senior roles across a variety of high growth technology companies. Prior to Uber, he served as SVP of Business Development and a member of the founding team at Swipely (now Upserve), one of the fastest growing payment companies in the US and part of Vista Equity Partners’ portfolio. Before Upserve, Jonathan was one of the first employees at Silicon Valley based Tellme, which revolutionized speech recognition systems and is used by millions of Americans daily. In 2007, Microsoft acquired Tellme in its then largest acquisition of a private company.

Jonathan began his career in private equity at Valor Equity Partners. He is an honors graduate of Vanderbilt University and lives in Charleston, SC  with his wife and three young boys.


Philippe Morel, MD, PhD
GI Surgical Oncology
Clinic General Beaulieu
  • Independent Surgeon, Clinic General Beaulieu of the Swiss Medical Network
  • Former Chief of Surgery, University Hospital Geneva
  • Specializes in pancreas, kidney, islets and liver transplantation and robotic surgery
  • Performed about 1,500 robotic surgical procedures to-date
Julie Lang, MD, FACS
Surgical Oncology
Keck School of Medicine, USC
  • Associate Professor of Clinical Surgery - Director, Breast Cancer Program
  • Expert in the field of breast surgical oncology, with strong expertise in both clinical care and research in the field of breast cancer
  • Research focused on circulating tumor cells, clinical trials, locally advanced/ inflammatory breast cancer and radiation-induced sarcoma
Marcia Cruz-Correa, MD, PhD
Surgical Oncology
Comprehensive Cancer Center, UPR
  • Professor of Medicine and Biochemistry
  • Leads a Gastrointestinal Oncology Program at the UPR Cancer Center; a multidisciplinary team of clinicians, basic and clinical scientists, and epidemiologists with an expertise in gastrointestinal cancer
  • Identifying genetic and epigenetic pathways for colorectal carcinogenesis among Hispanic patients
Jay Redan, MD, FACS
Surgical Oncology
  • Medical Director of Minimally Invasive General Surgery and directs the Chronic Abdominal and Pelvic PainProgram at AdventHealth
  • Expertise in robotic, single-site, incisionless and endoscopic surgical techniques
Minia Hellan, MD, FACS
Surgical Oncology
Kettering Medical Center
  • Surgical oncologist at Grandview Medical Center, Kettering Medical Center
  • Research in surgical oncology
  • Published dozens of articles, book chapters, and research papers on various topics in cancer treatment


Nathan Bahary, MD, PhD
Internal Medicine and Medical Oncology
University of Pittsburgh School of Medicine
  • Associate Professor at the University of Pittsburgh School of Medicine
  • Focus on identifying novel genes and pathways underlying normal gastrointestinal development and cancer
  • Design of rational molecularly-based disease markers for early detection of gastrointestinal cancers and therapies
Andrew E. Hendifar, MD, MPH
Medical Oncology
Cedars-Sinai Medical Center
  • Medical Director, Pancreatic Cancer, Assistant Professor of Medicine
  • Specialize in the treatment of pancreatic cancer, and carcinoid and neuroendocrine tumors
  • Developing several groundbreaking therapies, including radioimmunotherapy for neuroendocrine and pancreatic cancer


Setsuko K. Chambers, MD
Gynecologic Oncology
University of Arizona Cancer Center
  • Bobbi Olson Endowed Chair of Ovarian Cancer Research
  • Director of Women's Cancers, University of Arizona Cancer Center
  • Professor and Division Director of Gynecology Oncology, University of Arizona
  • Expertise in genetic counseling and management of women at risk for breast, ovarian and uterine cancers
Lynda Diane Roman, MD
Gynecologic Oncology
Keck School of Medicine, USC
  • Associate Professor of Obstetrics and Gynecology, Director of the Division of Gynecologic Oncology and Director of Research and Fellowship Program USC
  • Co-director of the Lynne Cohen & Georgia Cord Preventive Cancer Care Clinic at the USC/Norris Cancer Center
  • Gynecologic Medical Oncology, Gynecologic Oncology, Medical Oncology, OB and GYN


Michael B. Lilly, MD
Medical University of South Carolina
  • Associate Director of Translational Science, Hollings Cancer Center, Medical University of South Carolina
  • Specifically looking at antibody-targeted chemotherapy for a newly recognized form of prostate cancer using a new biomarker in blood tests


Andrew J. Hung, MD
Urologic Oncology
Keck Hospital of USC
  • Assistant Professor of Clinical Urology
  • Associate Residency Program Director
  • Director, Robotic Simulation &Education
  • Expert in robotic and laparoscopic surgery for cancer and benign diseases of the kidney, bladder and prostate, joins the University of Southern California'sInstitute of Urology
Mike M. Nguyen, MD
Keck School of Medicine, USC
  • Associate Professor of Clinical Urology
  • Robotic and minimally invasive approaches for patients who are best treated surgically including robotic kidney-sparing partial nephrectomy for kidney cancer, and robotic prostatectomy for prostate cancer
  • Member of the American Society of Clinical Oncology's (ASCO) Cancer Prevention Committee


Joshua A. Tepper, MD, FCFP, MPH
AMITA Health Saint Joseph Medical Center Joliet
  • Medical staff at Presence Saint Joseph Medical Center in Joliet
  • Member of the Internal Review Board(IRB), Cancer Committee, and is Director of the Vein Clinic
  • Principal investigator at Presence Saint Joseph Medical Center for the EVOLVE research trial on kyphoplasty
  • Minimally invasive vascular procedures


Dan Raz, MD, MAS
Surgical Oncology
City of Hope
  • Co-director, Lung Cancer and Thoracic Oncology Program and Assistant Professor, Division of Thoracic Surgery, Department of Surgery
  • Identifying new therapies to combat therapy resistance in lung cancer
  • Targeting specific epigenetic changes to improve platinum sensitivity in lung cancer
  • Studying barriers to lung cancer screening


Jorge Nieva, MD
Medical Oncology
Keck School of Medicine, USC
  • Associate Professor of Clinical Medicine
  • Pioneered new technology for the detection of cancer cells in the peripheral blood and discoveries related to the fundamental mechanisms of the immune system
  • Established a research program in virus-delivered cancer gene therapy and immunotherapy


Binoy Kumar Singh, MD, PhD
Northwell Health
  • Assistant Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
  • Coronary artery by pass, echocardiography, nuclear cardiology
  • Cardiovascular Disease - AmericanBoard of IM/Cardiovascular Disease


Anne Freund, MD
General Surgery
Kreiskrankenhaus MTK Kliniken
  • Chief Surgical resident position in the division of digestive, vascular and thoracic surgery at the Kreiskrankenhaus MTK Klinikenin Bad Soden, near Frankfurt, Germany
  • Focuses on the implementation of new surgical methods
  • She is the author and co-author ofa dozen of scientific articles and posters


Join Us